Recombinant factor VIIa in the treatment of bleeding

scientific article

Recombinant factor VIIa in the treatment of bleeding is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1309/D0G0C96V05CJ5B4J
P698PubMed publication ID14750250

P50authorMilton WanerQ16913495
P2093author name stringLouis M Fink
Paulette Mehta
Madhu V Midathada
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)124-137
P577publication date2004-01-01
P1433published inAmerican Journal of Clinical PathologyQ15750224
P1476titleRecombinant factor VIIa in the treatment of bleeding
P478volume121

Reverse relations

cites work (P2860)
Q82212913Acute Epidural Hematoma in a Patient With Glanzmann's Thrombasthenia -Case Report-
Q47324534Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.
Q42930655Control of Life-Threatening Head and Neck Hemorrhage After Dental Extractions: A Case Report
Q33214236Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity
Q36646985Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review
Q45866922Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008).
Q45881838Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias
Q36392691Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial

Search more.